-
BD to Highlight its Deep Commitment to Drug Delivery Innovation at Pharmapack
B3C newswire
January 15, 2024
A leading global medical technology company, will showcase numerous drug delivery innovations at Pharmapack 2024, which will take place on January 24-25, 2024 at Paris Expo, Porte de Versailles, in Paris.
-
BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes
PharmaSources
October 15, 2024
BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.
-
BD Showcases Latest Drug Delivery Innovations at CPhI Milan 2024
Pharmasources
October 14, 2024
BD (Becton, Dickinson and Company will highlight its newest innovations in drug delivery systems at CPhI Milan 2024
-
BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI 2023 Conference
B3C newswire
November 06, 2023
BD (Becton, Dickinson and Company), a leading global medical technology company, is excited to showcase at CPhI Barcelona 2023.
-
BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery
B3Cnewswire
October 15, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD SCF™ PremiumCoat®† Plunger Stopper in partnership with Aptar Pharma...
-
Pharmapack 2021: Pre-filled syringe technology could provide answers to future mass vaccination challenges, says BD
CPhIonline
October 13, 2021
Speaking at the Pharmapack Europe 2021 online conference in the session Responding to the Vaccine Delivery Challenges, Marie-Liesse Le Crofec, Global Portfolio Marketing Head...
-
BD Completes Study Investigating Performance of Glass Prefillable Syringes (PFS) in Deep Cold Storage
B3Cnewswire
September 28, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, completed a preliminary study investigating the impact of deep cold storage (-20°C and -40°C) on glass PFS.
-
BD and CerTest Biotec Announce CE Mark for Molecular Test to Detect, Identify Certain SARS-CoV-2 Variants
b3cnewswire
August 09, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the CE mark for a molecular test that can detect and distinguish between the Alpha (B.1.1.7), Beta (B.1.351) and Gamma (P.1) SARS-CoV-2 variants.
-
BD Hits 2 Billion Injection Device Milestone for COVID-19 Vaccinations
contractpharma
June 15, 2021
BD (Becton, Dickinson and Company) has received pandemic orders for needles and syringes totaling 2 billion injection devices to support global COVID-19 vaccination efforts.
-
BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain To Support Ongoing Strong Growth of Pre-Filled Drug Delivery Business
b3cnewswire
May 21, 2021
New plant will produce drug delivery devices, employ 150 people in 2024 and up to 600 when full operations start in 2030